293 related articles for article (PubMed ID: 30980713)
1. Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
Wu B; Tong J; Ran Z
Inflamm Bowel Dis; 2020 Jan; 26(1):24-32. PubMed ID: 30980713
[TBL] [Abstract][Full Text] [Related]
2. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
3. Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.
Nishio M; Ishii Y; Hashimoto Y; Otake H; Ogashiwa T; Tsuda S; Yasuhara H; Saigusa Y; Kimura H; Maeda S; Kunisaki R
Scand J Gastroenterol; 2018; 53(10-11):1236-1244. PubMed ID: 30353757
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.
Ollech JE; Dwadasi S; Rai V; Peleg N; Normatov I; Israel A; Sossenheimer PH; Christensen B; Pekow J; Dalal SR; Sakuraba A; Cohen RD; Rubin DT
Aliment Pharmacol Ther; 2020 Mar; 51(6):637-643. PubMed ID: 31875986
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.
Boschetti G; Nancey S; Moussata D; Stefanescu C; Roblin X; Chauvenet M; Stroeymeyt K; Bouhnik Y; Flourié B
Dig Liver Dis; 2014 Oct; 46(10):875-80. PubMed ID: 25023007
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
Pellet G; Stefanescu C; Carbonnel F; Peyrin-Biroulet L; Roblin X; Allimant C; Nachury M; Nancey S; Filippi J; Altwegg R; Brixi H; Fotsing G; de Rosamel L; Shili S; Laharie D;
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):494-501. PubMed ID: 30213584
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.
Zhao HN; Jiang M; Sun MJ; Dai C
Saudi J Gastroenterol; 2021; 27(4):191-200. PubMed ID: 34380865
[TBL] [Abstract][Full Text] [Related]
8. The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
Naganuma M; Fujii T; Watanabe M
J Gastroenterol; 2011 Feb; 46(2):129-37. PubMed ID: 21132334
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus as rescue therapy for steroid-dependent/steroid-refractory ulcerative colitis: Experience from tertiary referral center in India.
Sud S; Sachdeva S; Puri AS
Indian J Gastroenterol; 2021 Dec; 40(6):598-603. PubMed ID: 34971402
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
Christensen B; Gibson PR; Micic D; Colman RJ; Goeppinger SR; Kassim O; Yarur A; Weber CR; Cohen RD; Rubin DT
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):486-493. PubMed ID: 29751166
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience.
Benson A; Barrett T; Sparberg M; Buchman AL
Inflamm Bowel Dis; 2008 Jan; 14(1):7-12. PubMed ID: 17879277
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy.
Inoue T; Murano M; Narabayashi K; Okada T; Nouda S; Ishida K; Kawakami K; Abe Y; Takeuchi T; Tokioka S; Umegaki E; Higuchi K
Intern Med; 2013; 52(1):15-20. PubMed ID: 23291669
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
14. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
[TBL] [Abstract][Full Text] [Related]
15. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.
Kawakami K; Inoue T; Murano M; Narabayashi K; Nouda S; Ishida K; Abe Y; Nogami K; Hida N; Yamagami H; Watanabe K; Umegaki E; Nakamura S; Arakawa T; Higuchi K
World J Gastroenterol; 2015 Feb; 21(6):1880-6. PubMed ID: 25684955
[TBL] [Abstract][Full Text] [Related]
17. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
[TBL] [Abstract][Full Text] [Related]
18. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis.
Liu YJ; Fan H; Zhen WW; Yu X; Chen JT; Wang CD
Medicine (Baltimore); 2018 Aug; 97(32):e11440. PubMed ID: 30095612
[TBL] [Abstract][Full Text] [Related]
20. EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Lasa J; Olivera P
Arq Gastroenterol; 2017; 54(2):167-172. PubMed ID: 28327826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
